Role of central dopaminergic circuitry in pain processing and nitroglycerin-induced hyperalgesia

Brain Research

Volumn 1238, Issue , 2008, Pages 215-223

  Greco, Rosaria ^a   Tassorelli, Cristina ^a,b   Armentero, Marie Therèse ^a   Sandrini, Giorgio ^a,b   Nappi, Giuseppe ^a,b,c   Blandini, Fabio ^a  

^a C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^b Section of Pavia   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

6 OHDA; Basal ganglia; Flick test; Formalin test; Hyperalgesia; Nitroglycerin

Indexed keywords

FORMALDEHYDE; GLYCERYL TRINITRATE; OXIDOPAMINE; PROTEIN FOS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; HYPERALGESIA; HYPOTHALAMUS; MALE; NERVE CELL; NEUROTRANSMISSION; NONHUMAN; PAIN; PARABRACHIAL NUCLEUS; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STRIATONIGRAL DEGENERATION; TAIL FLICK TEST;

ADRENERGIC AGENTS; ANIMALS; BASAL GANGLIA; DENERVATION; DOPAMINE; FORMALDEHYDE; HYPERALGESIA; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; IRRITANTS; MALE; NITROGLYCERIN; OXIDOPAMINE; PAIN; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTIC TRANSMISSION; VASODILATOR AGENTS;

RATTUS;

EID: 55349106148     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.08.022     Document Type: Article

References (62)

1. Akerman S., and Goadsby P.J. Dopamine and migraine: biology and clinical implications Cephalalgia 27 2007 1308 1314
2. Armentero M.T., Fancellu R., Nappi G., Bramanti P., and Blandini F. Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease Neurobiol. Dis. 22 2006 1 9
3. Barbanti P., Fabbrini G., Vanacore N., Rum A., Lenzi G.L., Meco G., and Cerbo R. Dopamine and migraine: does Parkinson's disease modify migraine course? Cephalalgia 20 2000 720 723
4. Bes A., Dupui P., Guell A., Bessoles G., and Geraud G. Pharmacological exploration of dopamine hypersensitivity in migraine patients Int. J. Clin. Pharmacol. Res. 6 1986 189 192
5. Blandini F., Armentero M.T., Fancellu R., Blaugrund E., and Nappi G. Neuroprotective effect of rasagiline in a rodent model of Parkinson's disease Exp. Neurol. 187 2004 455 459
6. Bodenmann P., Ghika J., Van Melle G., and Bogousslavsky J. Neurological comorbidity in parkinsonism Rev. Neurol. (Paris) 157 2001 45 54
7. Brefel-Courbon C., Payoux P., Thalamas C., Ory F., Quelven I., Chollet F., Montastruc J.L., and Rascol O. Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study Mov. Disord. 20 2005 1557 1563
8. Chudler E.H., and Dong W.K. The role of the basal ganglia in nociception and pain Pain 60 1995 3 38
9. D'Andrea G., Granella F., Perini F., Farruggio A., Leone M., and Bussone G. Platelet levels of dopamine are increased in migraine and cluster headache Headache 46 2006 585 591
10. Dalsgaard-Nielsen T., Bryndum B., Fog-Moeller F., and Genefke I.K. The effect of percutaneous nitroglycerin upon the concentration of serotonin, epinephrine and norepinephrine in venous blood from migrainous subjects during attack-free intervals Headache 14 1975 231 234
11. de Vente J., Markerink-van Ittersum M., van Abeelen J., Emson P.C., Axer H., and Steinbusch H.W. NO-mediated cGMP synthesis in cholinergic neurons in the rat forebrain: effects of lesioning dopaminergic or serotonergic pathways on nNOS and cGMP synthesis Eur. J. Neurosci. 12 2000 507 519
12. Fanciullacci M., Alessandri M., and Del Rosso A. Dopamine involvement in the migraine attack Funct. Neurol. 15 Suppl 3 2000 171 181
13. Fernandez A., de Ceballos M.L., Jenner P., and Marsden C.D. Striatal neuropeptide levels in Parkinson's disease patients Neurosci. Lett. 145 1992 171 174
14. Ferreira S.H. The role of interleukins and nitric oxide in the mediation of inflammatory pain and its control by peripheral analgesics Drugs 46 Suppl 1 1993 1 9
15. Greco R., Tassorelli C., Cappelletti D., Sandrini G., and Nappi G. Activation of the transcription factor NF-kappaB in the nucleus trigeminalis caudalis in an animal model of migraine Neurotoxicology 26 2005 795 800
16. Greco R., Tassorelli C., Sandrini G., Di Bella P., Buscone S., and Nappi G. Role of calcitonin gene-related peptide and substance P in different models of pain Cephalalgia 28 2008 114 126
17. Iversen H.K., and Olesen J. Nitroglycerin-induced headache is not dependent on histamine release: support for a direct nociceptive action of nitric oxide Cephalalgia 14 1994 437 442
18. Jurna I., Heinz G., Blinn G., and Nell T. The effect of substantia negra stimulation and morphine on alpha-motoneurones and the tail-flick response Eur. J. Pharmacol. 51 1978 239 250
19. Kirik D., Rosenblad C., and Bjorklund A. Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor Eur. J. Neurosci. 12 2000 3871 3882
20. Kitahama K., Nagatsu I., Geffard M., and Maeda T. Distribution of dopamine-immunoreactive fibers in the rat brainstem J. Chem. Neuroanat. 18 2000 1 9
21. Kitahama K., Nagatsu I., Geffard M., and Maeda T. Distribution of dopamine-immunoreactive fibers in the rat brainstem J. Chem. Neuroanat. 18 2000 1 9
22. Kline D.D., Takacs K.N., Ficker E., and Kunze D.L. Dopamine modulates synaptic transmission in the nucleus of the solitary tract J. Neurophysiol. 88 2002 2736 2744
23. Lambert G.A., Donaldson C., Boers P.M., and Zagami A.S. Activation of trigeminovascular neurons by glyceryl trinitrate Brain Res. 887 2000 203 210
24. LaPorta L.D. Relief from migraine headache with aripiprazole treatment Headache 47 2007 922 926
25. Levy M.J., Matharu M.S., Meeran K., Powell M., and Goadsby P.J. The clinical characteristics of headache in patients with pituitary tumours Brain 128 2005 1921 1930
26. Lin M.T., Wu J.J., Chandra A., and Tsay B.L. Activation of striatal dopamine receptors induces pain inhibition in rats J. Neural Transm. 51 1981 213 222
27. Lindefors N., Brodin E., Tossman U., Segovia J., and Ungerstedt U. Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation Exp. Brain Res. 74 1989 527 534
28. Magnusson J.E., and Fisher K. The involvement of dopamine in nociception: the role of D(1) and D(2) receptors in the dorsolateral striatum Brain Res. 855 2000 260 266
29. Mansikka H., Erbs E., Borrelli E., and Pertovaara A. Influence of the dopamine D2 receptor knockout on pain-related behavior in the mouse Brain Res. 1052 2005 82 87
30. Martikainen I.K., Hagelberg N., Mansikka H., Hietala J., Nagren K., Scheinin H., and Pertovaara A. Association of striatal dopamine D2/D3 receptor binding potential with pain but not tactile sensitivity or placebo analgesia Neurosci. Lett. 376 2005 149 153
31. Mascia A., Afra J., and Schoenen J. Dopamine and migraine: a review of pharmacological, biochemical, neurophysiological, and therapeutic data Cephalalgia 18 1998 174 182
32. Meller S.T., and Gebhart G.F. Nitric oxide (NO) and nociceptive processing in the spinal cord Pain 52 1993 127 136
33. Nuyen J., Schellevis F.G., Satariano W.A., Spreeuwenberg P.M., Birkner M.D., van den Bos G.A.M., and Groenewegen P.P. Comorbidity was associated with neurologic and psychiatric diseases: a general practice-based controlled study J. Clin. Epidemiol. 59 2006 1274 1284
34. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates Vol. 2 1998 Academic Press San Diego 143 pp
35. Peroutka S.J. Dopamine and migraine Neurology 49 1997 650 656
36. Perrotta A., Serrao M., Bartolo M., Valletta L., Locuratolo N., Pujia F., Fattapposta F., Bramanti P., Amabile G.A., Pierelli F., and Parisi L. Abnormal head nociceptive withdrawal reaction to facial nociceptive stimuli in Parkinson's disease Clin. Neurophysiol. 116 2005 2091 2098
37. Pertovaara A., Martikainen I.K., Hagelberg N., Mansikka H., Nagren K., Hietala J., and Scheinin H. Striatal dopamine D2/D3 receptor availability correlates with individual response characteristics to pain Eur. J. Neurosci. 20 2004 1587 1592
38. Peterfreund R.A., Kosofsky B.E., and Fink J.S. Cellular localization of dopamine D2 receptor messenger RNA in the rat trigeminal ganglion Anesth. Analg. 81 1995 1181 1185
39. Reuter U., Chiarugi A., Bolay H., and Moskowitz M.A. Nuclear factor-kappaB as a molecular target for migraine therapy Ann. Neurol. 51 2002 507 516
40. Saade N.E., Atweh S.F., Bahuth N.B., and Jabbur S.J. Augmentation of nociceptive reflexes and chronic deafferentation pain by chemical lesions of either dopaminergic terminals or midbrain dopaminergic neurons Brain Res. 751 1997 1 12
41. Sahach V.F., Baziliuk O.V., Oleshko M.M., Kotsiuruba O.V., Bukhanevych O.M., and Appenzeller O. The nitric oxide system in a chronic deficiency of mesostriatal dopamine: the action of nitroglycerin Fiziol. Zh. 46 2000 55 63
42. Sances G., Tassorelli C., Pucci E., Ghiotto N., Sandrini G., and Nappi G. Reliability of the nitroglycerin provocative test in the diagnosis of neurovascular headaches Cephalalgia 24 2004 110 119
43. Sancesario G., Giorgi M., D'Angelo V., Modica A., Martorana A., Morello M., Bengtson C.P., and Bernardi G. Down-regulation of nitrergic transmission in the rat striatum after chronic nigrostriatal deafferentation Eur. J. Neurosci. 20 2004 989 1000
44. Sandberg D.E., and Segal M. Pharmacological analysis of analgesia and self-stimulation elicited by electrical stimulation of catecholamine nuclei in the rat brain Brain Res. 152 1978 529 542
45. Scott D.J., Heitzeg M.M., Koeppe R.A., Stohler C.S., and Zubieta J.K. Variations in the human pain stress experience mediated by ventral and dorsal basal ganglia dopamine activity J. Neurosci. 26 2006 10789 10795
46. Sicuteri F., Del Bene E., Poggioni M., and Bonazzi A. Unmasking latent dysnociception in healthy subjects Headache 27 1987 180 185
47. Sivam S.P., and Krause J.E. Compensatory activation of substance P biosynthesis by L-dihydroxyphenylalanine in striatonigral neurons of neonatal dopaminergic denervated rats J. Pharmacol. Exp. Ther. 254 1990 433 439
48. Srikiatkhachorn A., Suwattanasophon C., Ruangpattanatawee U., and Phansuwan-Pujito P. 2002 Wolff Award. 5-HT2A receptor activation and nitric oxide synthesis: a possible mechanism determining migraine attacks Headache 42 2002 566 574
49. Swanson L.W., and Sawchenko P.E. Paraventricular nucleus: a site for the integration of neuroendocrine and autonomic mechanisms Neuroendocrinology 31 1980 410 417
50. Takeda R., Ikeda T., Tsuda F., Abe H., Hashiguchi H., Ishida Y., and Nishimori T. Unilateral lesions of mesostriatal dopaminergic pathway alters the withdrawal response of the rat hindpaw to mechanical stimulation Neurosci. Res. 52 2005 31 36
51. Tassorelli C., and Joseph S.A. NADPH-diaphorase activity and Fos expression in brain nuclei following nitroglycerin administration Brain Res. 695 1995 37 44
52. Tassorelli C., and Joseph S.A. Systemic nitroglycerin induces Fos immunoreactivity in brainstem and forebrain structures of the rat Brain Res. 682 1995 167 181
53. Tassorelli C., and Joseph S.A. Systemic nitroglycerin activates peptidergic and catecholaminergic pathways in rat brain Peptides 17 1996 443 449
54. Tassorelli C., Joseph S.A., and Nappi G. Neurochemical mechanisms of nitroglycerin-induced neuronal activation in rat brain: a pharmacological investigation Neuropharmacology 36 1997 1417 1424
55. Tassorelli C., Joseph S.A., and Nappi G. Reciprocal circuits involved in nitroglycerin-induced neuronal activation of autonomic regions and pain pathways: a double immunolabeling and tract-tracing study Brain Res. 842 1999 294 310
56. Tassorelli C., Costa A., Blandini F., Joseph S.A., and Nappi G. Effect of nitric oxide donors on the central nervous system-nitroglycerin studies in the rat Funct. Neurol. 15 Suppl 3 2000 19 27
57. Tassorelli C., Greco R., Wang D., Sandrini M., Sandrini G., and Nappi G. Nitroglycerin induces hyperalgesia in rats-a time-course study Eur. J. Pharmacol. 464 2003 159 162
58. Tassorelli C., Blandini F., Greco R., and Nappi G. Nitroglycerin enhances cGMP expression in specific neuronal and cerebrovascular structures of the rat brain J. Chem. Neuroanat. 27 2004 23 32
59. Tassorelli C., Greco R., Wang D., Sandrini G., and Nappi G. Prostaglandins, glutamate and nitric oxide synthase mediate nitroglycerin- induced hyperalgesia in the formalin test Eur. J. Pharmacol. 534 2006 103 107
60. Tassorelli C., Armentero M.T., Greco R., Fancellu R., Sandrini G., Nappi G., and Blandini F. Behavioral responses and Fos activation following painful stimuli in a rodent model of Parkinson's disease Brain Res. 1176 2007 53 61
61. Tjolsen A., Berge O.G., Hunskaar S., Rosland J.H., and Hole K. The formalin test: an evaluation of the method Pain 51 1992 5 17
62. van Hilten J.J. The migraine-dopamine link: do migraine and Parkinson's disease coexist? Clin. Neurol. Neurosurg. 94 Suppl 1992 S168 S170